" class="no-js "lang="en-US"> Andy Beck - Medtech Alert
Friday, August 01, 2025
Andy Beck

Andy Beck

About Andy Beck

Andy earned his MD from Brown Medical School and completed residency and fellowship training in Anatomic Pathology and Molecular Genetic Pathology from Stanford University. He completed a PhD in Biomedical Informatics from Stanford University, where he developed one of the first machine-learning based systems for cancer pathology. He’s been certified by the American Board of Pathology in Anatomic Pathology and Molecular Genetic Pathology. Prior to co-founding PathAI, he was on the faculty of Harvard Medical School in the Department of Pathology at Beth Israel Deaconess Medical Center. He has published over 110 papers in the fields of cancer biology, cancer pathology, and biomedical informatics.

Related Story

PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb

August 26 2022

PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb. […]

Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care

October 15 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]

PathAI Announces Completion of $165 Million Financing for Advancing Medicine with AI-powered Pathology

May 20 2021

PathAI, a global provider of artificial intelligence-powered technology for pathology, announced today the closing of […]